Anonymous
Guest
Anonymous
Guest
So let me see if I have this right. Cadence gets bought for $1.3 Billion, and they have one drug that in inferior to ours in every way EXCEPT for how it was launched, and the sales and marketing strategies since launch. Meanwhile we have multiple brands and based on todays pricing we have a Market Cap of $84.55 Million. I am not the smartest gal in the world, but it sounds like on CEO did a really good job and one CEO has done a really lousy job. Am I right, or am I missing something?